|
CCDC99 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.84199996869461E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.13090000486827E-08 |
| Normal-vs-Stage2 |
1.582690E-04 |
| Normal-vs-Stage3 |
2.12590000048252E-07 |
| Normal-vs-Stage4 |
5.785799994662E-08 |
| Stage1-vs-Stage2 |
9.127400E-01 |
| Stage1-vs-Stage3 |
2.347400E-01 |
| Stage1-vs-Stage4 |
1.004640E-01 |
| Stage2-vs-Stage3 |
4.049000E-01 |
| Stage2-vs-Stage4 |
1.814360E-01 |
| Stage3-vs-Stage4 |
5.594200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0787000004342E-07 |
| Normal-vs-AfricanAmerican |
1.8693699999961E-05 |
| Normal-vs-Asian |
3.75239999994559E-06 |
| Caucasian-vs-AfricanAmerican |
2.746600E-01 |
| Caucasian-vs-Asian |
9.150400E-01 |
| AfricanAmerican-vs-Asian |
2.727400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44929999999588E-05 |
| Normal-vs-Female |
2.95329982691328E-10 |
| Male-vs-Female |
2.784000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.14699999948154E-07 |
| Normal-vs-Age(41-60Yrs) |
2.61719979022246E-10 |
| Normal-vs-Age(61-80Yrs) |
4.51290000003102E-06 |
| Normal-vs-Age(81-100Yrs) |
4.146800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.624400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.856200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.265200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.550560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.374200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.255400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.917000E-01 |
| Classical-VS-Follicular |
3.985600E-01 |
| Classical-VS-Other |
9.118600E-01 |
| Classical-VS-Normal |
1.66039999971446E-07 |
| Tall-VS-Follicular |
6.423000E-01 |
| Tall-VS-Other |
6.815200E-01 |
| Tall-VS-Normal |
2.14570000000025E-05 |
| Follicular-VS-Other |
8.723800E-01 |
| Follicular-VS-Normal |
8.07970000016311E-07 |
| Other-VS-Normal |
4.630200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26290000002083E-06 |
| Normal-vs-N1 |
5.90079999973625E-07 |
| N0-vs-N1 |
2.238400E-01 |
|
|
